| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/25/2002 | CN1371291A Method and formula for tumor remission and suppression of cancer |
| 09/25/2002 | CN1371288A Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body |
| 09/25/2002 | CN1371287A Preserved pharmaceutical formulations |
| 09/25/2002 | CN1371284A Multi-dose erythropoietin formulations |
| 09/25/2002 | CN1371283A Use of propionic bacteria for producing propionic acid and/or propionates in colon |
| 09/25/2002 | CN1371278A Pharmaceutically stable oxaliplatinum preparation for parenteral administration |
| 09/25/2002 | CN1371277A Pharmaceutical tramadol salts |
| 09/25/2002 | CN1371275A Arificial tear replacement solution |
| 09/25/2002 | CN1371268A Cosmetic and/or pharmaceutical preparations with polymers containing polysiloxanes and the uses thereof |
| 09/25/2002 | CN1370601A Prepn of single-component slowly released genetically engineered hepatitis B vaccine microballoon |
| 09/25/2002 | CN1370600A Resin type ointment and its prepn |
| 09/24/2002 | WO2001072289A2 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 09/24/2002 | US6455673 Polypeptide for use as vaccine in prevention of microorganismal infections |
| 09/24/2002 | US6455671 Thrombin inhibitors, the preparation and use thereof |
| 09/24/2002 | US6455592 Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions |
| 09/24/2002 | US6455588 Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| 09/24/2002 | US6455586 Human contact sensitizers; vehicles consisting of non-volatile, nonionic surfactants and esters of isopropyl alcohol and myristic acid and palmitic acid |
| 09/24/2002 | US6455574 Administering a combinations of amlodipine or a pharmaceutically acceptable acid addition salt thereof and atorvastatin or a pharmaceutically acceptable salt thereof for treatment of combined hypertension and hyperlipidemia |
| 09/24/2002 | US6455565 Method for inhibiting skin lesion formation using histamine as the active ingredient |
| 09/24/2002 | US6455547 Method for treating pharmaceutical compositions |
| 09/24/2002 | US6455533 Substituted benzhydrylpiperazines such as cetirizine, hydroxyzine, efletirizine, meclizine and buclizine, the optically active isomers thereof and the pharmaceutically acceptable salts thereof. |
| 09/24/2002 | US6455503 Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
| 09/24/2002 | US6455498 Structural alterations of the EGF receptor genes in human tumors |
| 09/24/2002 | US6455496 NL2 TIE ligand homologue polypeptide |
| 09/24/2002 | US6455495 Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents |
| 09/24/2002 | US6455493 Methods for using heat shock proteins |
| 09/24/2002 | US6455251 Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| 09/24/2002 | US6455090 Liquid additive for thickener |
| 09/24/2002 | US6455088 Peptide/lipid complex formation by co-lyophilization |
| 09/24/2002 | US6455076 Formulations and methods for reducing skin irritation |
| 09/24/2002 | US6455074 Methods of forming and using the device for the sustained release of an active agent. the improved method of the invention for forming a polymer-based sustained release device comprises forming a polymer/active agent solution by mixing a |
| 09/24/2002 | US6455072 Stable aqueous dispersion of nutrients |
| 09/24/2002 | US6455071 Branched dendrimeric structures |
| 09/24/2002 | US6455069 Directly compressible starch as enhancer of properties of excipients when used as binder and disintegrant for compression tablets |
| 09/24/2002 | US6455067 Alkyl-pyrrolidone 0.5-10 weight %, hydrophilic polyalkylene glycol 1-15 weight %, hydrophilic nonionic surfactant 0.01-3 weight %, water soluble polymer having carboxyl group 2-15 weight %, water soluble vinyl polymer 0.1-10 weight %, water |
| 09/24/2002 | US6455066 Intradermal-penetration agents for topical local anesthetic administration |
| 09/24/2002 | US6455064 A kit for delivering a medicament to a patient, comprising a package containing: a container with drugs, catalysts and monomer |
| 09/24/2002 | US6455052 A composition for forming an enteric coating on a tablet, capsule or pellet for oral ingestion includes a liquid mixture of alginic acid particles gelatine, vegetable hydrocolloids and/or animal protein. |
| 09/24/2002 | US6455047 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | US6455030 The sheet pressure-sensitive adhesive layer containing a medicine; water insolubility; surface anesthesia, dentistry |
| 09/24/2002 | US6455026 Use of protein tyrosine phosphatase zeta as a biomolecular target in the treatment and visualization of brain tumors |
| 09/24/2002 | US6455025 Polysaccharide-peptide derivatives |
| 09/24/2002 | US6455024 Particles of an inorganic material containing a radionuclide and having a specified particle size in microns; radiotherapy |
| 09/24/2002 | CA2404322A1 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 09/24/2002 | CA2246282C Process for the stabilization and dispersion of vegatable oils comprising polyunsaturated fatty acid radicals by means of gamma-cyclodextrin |
| 09/24/2002 | CA2105282C Preparation of factor ix |
| 09/24/2002 | CA2083161C Branched polyanhydrides |
| 09/20/2002 | CA2377453A1 Method of preventing retinopathy of prematurity in a neonate |
| 09/19/2002 | WO2002072811A2 Human prenylcysteine lyase-like protein |
| 09/19/2002 | WO2002072636A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/19/2002 | WO2002072631A2 Mhc molecule constructs and their usesfor diagnosis and therapy |
| 09/19/2002 | WO2002072620A1 Tumour targeting prodrugs activated by metallo matrixproteinases |
| 09/19/2002 | WO2002072616A2 Transfection complexes |
| 09/19/2002 | WO2002072606A2 Epitope testing using hla |
| 09/19/2002 | WO2002072598A1 Steroids as agonists for fxr |
| 09/19/2002 | WO2002072594A1 Branched cyclic tetrassacharide, process for producing the same, and use |
| 09/19/2002 | WO2002072448A1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
| 09/19/2002 | WO2002072166A1 Compositions for drug delivery |
| 09/19/2002 | WO2002072164A1 Hydrocolloid compositions |
| 09/19/2002 | WO2002072152A1 Gene carriers with the use of polysaccharide and process for producing the same |
| 09/19/2002 | WO2002072151A1 Enzyme-activated cytostatic conjugates with integrin ligands |
| 09/19/2002 | WO2002072150A2 Micellar drug delivery vehicles and uses thereof |
| 09/19/2002 | WO2002072148A1 Compositions and methods for non-insulin glucose uptake |
| 09/19/2002 | WO2002072135A1 LIQUID INTERFERON α PREPARATIONS FOR INJECTION AND METHOD OF STABILIZING THE SAME |
| 09/19/2002 | WO2002072118A1 Process for obtention of decoctions of vitis labrusca and vitis vinifera skins |
| 09/19/2002 | WO2002072112A1 Use of selenite or preparations containing selenite for treating wounds |
| 09/19/2002 | WO2002072111A1 Telithromycin suspension with a masked taste |
| 09/19/2002 | WO2002072108A1 Use of fluticasone propionate in the treatment of diseases ameliorated by enhancement of epithelial/matrix adhesion such as asthma, cystic fibrosis and influenza |
| 09/19/2002 | WO2002072107A1 Topical composition containing hydrocortisone |
| 09/19/2002 | WO2002072102A1 Taste masked liquid pharmaceutical compositions |
| 09/19/2002 | WO2002072100A2 Pharmaceutical composition containing pde v inhibitors and surfactants |
| 09/19/2002 | WO2002072095A2 Tiotropium salts for treating inflammatory diseases |
| 09/19/2002 | WO2002072081A1 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same |
| 09/19/2002 | WO2002072080A2 Paracetamol solutions which are stable in storage and ready for infusion |
| 09/19/2002 | WO2002072075A1 Oral peptide pharmaceutical dosage form and method of production |
| 09/19/2002 | WO2002072073A2 Pharmaceutical formulation comprising atorvastatin calcium |
| 09/19/2002 | WO2002072072A2 Granules and granules coated with a masked taste |
| 09/19/2002 | WO2002072066A1 Composition for rectal delivery of an oxazolidinone antibacterial drug |
| 09/19/2002 | WO2002072054A1 Emulsion composition |
| 09/19/2002 | WO2002072047A2 Cosmetic or pharmaceutical agent |
| 09/19/2002 | WO2002072037A1 Topical dermal anaesthetic |
| 09/19/2002 | WO2002072034A2 Chronotherapeutic dosage forms |
| 09/19/2002 | WO2002072033A2 Chronotherapeutic dosage forms containing glucocorticosteroid |
| 09/19/2002 | WO2002072018A2 A cream-t0-powder dermatological composition |
| 09/19/2002 | WO2002072011A2 Stabilized therapeutic and imaging agents |
| 09/19/2002 | WO2002072010A2 Taxane prodrugs |
| 09/19/2002 | WO2002072003A2 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour |
| 09/19/2002 | WO2002055532A3 Variant growth hormone molecules conjugated with macromolecular compounds |
| 09/19/2002 | WO2002053617B1 Linear block polymer |
| 09/19/2002 | WO2002053184A3 Uses for polycationic compounds as vaccine adjuvants |
| 09/19/2002 | WO2002049624A3 Novel pharmaceutical compositions based on anticholinergic agents and dopamine agonists |
| 09/19/2002 | WO2002038577A3 Extended release erythromycin derivatives |
| 09/19/2002 | WO2002036106A3 Novel medicament compositions based on anticholinergics and corticosteroids |
| 09/19/2002 | WO2002030409A8 Methods for the treatment of a traumatic central nervous system injury |
| 09/19/2002 | WO2002024158A3 Pulmonary delivery in treating disorders of the central nervous system |
| 09/19/2002 | WO2002020018A8 Tablets containing epinastine manufactured by direct compression |
| 09/19/2002 | WO2002004487A3 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 09/19/2002 | WO2002002189A3 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
| 09/19/2002 | WO2002000870A9 Method for transfecting cells using a magnetic field |